Author(s): Gangadhar Hari, Anusha Prabhu, Chaitanyamayee Kalakota, Jeslin Johnson, Kufaila Mansoor, Rekha R Shenoy, Karkala Sreedhara Ranganath Pai, Krishnadas Nandakumar

Email(s): mailnadakumar77@gmail.com , nandakumar.k@manipal.edu

DOI: 10.52711/0974-360X.2022.00749   

Address: Gangadhar Hari, Anusha Prabhu, Chaitanyamayee Kalakota, Jeslin Johnson, Kufaila Mansoor, Rekha R Shenoy, Karkala Sreedhara Ranganath Pai, Krishnadas Nandakumar*
Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka - 576104.
*Corresponding Author

Published In:   Volume - 15,      Issue - 10,     Year - 2022


ABSTRACT:
Psoriasis is a chronic inflammatory autoimmune skin disorder, generally due to the interaction between genetic, environmental and immune factors. It is mainly associated with HLA locus (HLA-C), particularly with HLA-Cw* 0602 allele. The stimulation of T-cell induces hyper-proliferation of keratinocytes, which results in psoriatic lesions. Psoriatic patients are usually treated with medications that block TNF-a function. Complexities in the pathogenesis of psoriasis have been a challenge to develop an effective treatment regimen. Thus, studies are still underway for exploring drugs to treat psoriasis. Researchers have reported the antioxidant, antibacterial and anti-inflammatory properties of the structural half analogue of curcumin, dehydrozingerone (DHZ). Pre-clinical studies have reported the wound healing and anti-inflammatory properties of this compound. DHZ is also capable of blocking TNF alpha, which is one of the early cytokines implicated in psoriasis. Therefore, the current study has been proposed to explore the effect of DHZ to reduce psoriatic like lesions in imiquimod-induced psoriasis in mice. Upon the development of psoriatic like lesions, clinical scoring for scaling and erythema was taken on a scale of 0-4. DHZ has shown a significant reduction of scaling in comparison to the disease control, denoting the effectiveness of the test drug.


Cite this article:
Gangadhar Hari, Anusha Prabhu, Chaitanyamayee Kalakota, Jeslin Johnson, Kufaila Mansoor, Rekha R Shenoy, Karkala Sreedhara Ranganath Pai, Krishnadas Nandakumar. Research Journal of Pharmacy and Technology2022; 15(10):4469-2. doi: 10.52711/0974-360X.2022.00749

Cite(Electronic):
Gangadhar Hari, Anusha Prabhu, Chaitanyamayee Kalakota, Jeslin Johnson, Kufaila Mansoor, Rekha R Shenoy, Karkala Sreedhara Ranganath Pai, Krishnadas Nandakumar. Research Journal of Pharmacy and Technology2022; 15(10):4469-2. doi: 10.52711/0974-360X.2022.00749   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-10-22


REFERENCES:
1.    Taha MM, Al-Asady ZT. Evaluation of the effectiveness of antioxidants and TNF-α in Iraqi patients with psoriasis treated with Etanercept. Research Journal of Pharmacy and Technology. 2019;12(2):665-668. doi:10.5958/0974-360X.2019.00118.5
2.    Ayala-Fontánez N. et al. Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl). 2016 Feb 22;6:7-32. doi: 10.2147/PTT.S64950.
3.    Gudjonsson JE et al. Johnston A, Sigmundsdottir H, Valdimarsson H. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol. 2004 Jan;135(1):1-8. doi: 10.1111/j.1365-2249.2004.02310.x.
4.    Cai Y, Fleming C, Yan J. New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol. 2012 Jul;9(4):302-9. doi: 10.1038/cmi.2012.15. Epub 2012 Jun 18. PMID: 22705915; PMCID: PMC4132586.
5.    Tobin AM, Kirby B. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. BioDrugs. 2005;19(1):47-57. doi: 10.2165/00063030-200519010-00006. PMID: 15691217.
6.    Parag Sukare, Rupa Bhattacharya. Herbal plant used in Treatment of Psoriasis - A Systematic Review. Res. J. Pharmacognosy and Phytochem. 2020; 12(1):. 57-62. doi: 10.5958/0975-4385.2020.00011.4
7.    Aparna Satapathy, Mandava V. Rao. Protective effect of Curcumin on 2, 4- Dichlorophenoxy acetic acid exerted Hepatotoxicity in Mice. Research J. Pharm. and Tech 2018; 11(2):637-642. doi: 10.5958/0974-360X.2018.00119.1
8.    P. Venugopalan, T. V. Deepthi. Chemical and Pharmacological Studies on Curcuminoids. Asian J. Research Chem. 7(3): March 2014; Page 355-365.
9.    Kishu Tripathi. “Curcumin-The Spice of Life-II.” Research J. Pharmacognosy and Phytochemistry 2009; 1(3): 162-168.
10.    Amalraj, Augustine et al. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives - A review. J Tradit Complement Med. 2016 Jun 15;7(2):205-233. doi: 10.1016/j.jtcme.2016.05.005.
11.    Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105-25. doi: 10.1007/978-0-387-46401-5_3.
12.    S.B. Patil, V.V. Patil, D.S. Ghodke, M.S. Kondawar, N.S. Naikwade, C.S. Magdum. Formulation of Gel and Its UV Protective Study of Some Medicinal Flowers. Asian J. Pharm. Ana. 1(2): April-June 2011; Page 34-35.
13.    Nirmala Gupta et al. Chemopreventive potential of Aegle marmelos fruit extract against 7, 12-Dimethylbenz (a)anthracene-Induced Skin Papillomagenesis in Mice. Research J. Pharmacology and Pharmacodynamics. 2012; 4(2): 87-90 . Available on: https://rjppd.org/AbstractView.aspx?PID=2012-4-2-15
14.    Yogesh R. Joshi et al. Effect of Nimodipine alone and in combination with Gabapentin against Pentylenetetrazole induced Seizures in Mice. Asian J. Pharm. Res. 2018; 8(4): 215-220. doi: 10.5958/2231-5691.2018.00036.9
15.    Sabale Prafulla et al. Novel Curcumin Derivatives: Targeted for Anti-Inflammatory Activity. Asian J. Research Chem. 2019; 12(2):49-54. doi: 10.5958/0974-4150.2019.00011.7
16.    Li, Sara Jiayang et al. TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management. J Psoriasis Psoriatic Arthritis. 2019 Apr;4(2):70-80. doi: 10.1177/2475530318810851.
17.    Rahamat Unissa et al. Psoriasis: A Comprehensive Review. Asian J. Res. Pharm. Sci. 2019; 9(1):29-38. doi: 10.5958/2231-5659.2019.00005.5
18.    Vijayalakshmi. A et al. Antimicrobial activity of Antipsoriatic Plant Givotia rottleriformis Griff. Ex Wight. Research J. Pharm. and Tech 2016; 9(8):1109-1114. doi: 10.5958/0974-360X.2016.00210.9.
19.    Sumithra. M et al. Cell Lines and Animal Models of Psoriasis. Research J. Pharm. and Tech 2020; 13(3):1601-1608. doi: 10.5958/0974-360X.2020.00290.5
20.    Jacquiline Habashy and David T Robles. Psoriasis: Practice Essentials, Background, Pathophysiology. 20. Feb. 2020. emedicine.medscape.com. Available on: https://emedicine.medscape.com/article/1943419-overview
21.    Kumar, V. et al. Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-Book. 9th ed. Philadelphia. 2020.
22.    Psoriasis - Diagnosis and treatment. Feb. 2020. mayoclinic.org. Available on: https://www.mayoclinic.org/diseases-conditions/psoriasis/diagnosis-treatment/drc-20355845
23.    Thappa DM, Malathi M. Topical therapy of psoriasis: Where do we stand? J Postgrad Med. 2017 Oct-Dec;63(4):210-212. doi: 10.4103/jpgm.JPGM_155_17.
24.    Torsekar R, Gautam MM. Topical Therapies in Psoriasis. Indian Dermatol Online J. 2017 Jul-Aug;8(4):235-245. doi: 10.4103/2229-5178.209622.
25.    Mose KF et al. Anti-inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone. British Journal of Clinical Pharmacology. 2018 Aug;84(8):1719-1728. DOI: 10.1111/bcp.13596.
26.    Phototherapy for Psoriasis: Types, Home Therapy, Cost & More. Feb. 2020. healthline.com. Available on: https://www.healthline.com/health/psoriasis/phototherapy-treatment-options
27.    Lin YK, et al. Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs. PLoS One. 2015 Sep 10;10(9):e0137890. doi: 10.1371/journal.pone.0137890.
28.    Wu JK, Siller G, Strutton G. Psoriasis induced by topical imiquimod. Australas J Dermatol. 2004 Feb;45(1):47-50. doi: 10.1111/j.1440-0960.2004.00030.x.
29.    Patrizi A, et al. Management of atopic dermatitis: safety and efficacy of phototherapy. Clin Cosmet Investig Dermatol. 2015 Oct 5;8:511-20. doi: 10.2147/CCID.S87987.
30.    InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Psoriasis: Oral medications and injections. 2017 May 18. Available from: https://www.ncbi.nlm.nih.gov/books/NBK435704/

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available